No single vitamin has been proven to prevent or cure cancer, and several popular supplements can actually increase cancer risk in certain people. The evidence is more nuanced than most people expect: vitamin D is the strongest candidate for reducing cancer deaths, but high-dose supplements of vitamins like E, B12, and beta-carotene have been linked to higher cancer rates in large clinical trials. What matters is which vitamin, what dose, and who’s taking it.
Vitamin D: The Strongest Evidence for Lower Cancer Deaths
Vitamin D is the most consistently supported vitamin for cancer-related benefit, but the benefit is specific. It doesn’t appear to prevent cancer from developing in the first place. Instead, it reduces the chance of dying from cancer once it occurs. A meta-analysis of randomized controlled trials published in the Annals of Oncology found that vitamin D supplementation was associated with a 13% reduction in cancer mortality over 3 to 10 years of follow-up.
The catch: this benefit only appeared with daily dosing, not with large infrequent doses taken weekly or monthly. The protective effect held even when blood levels of vitamin D stayed in a moderate range, suggesting you don’t need megadoses to see results. Researchers believe vitamin D may help regulate how cancer cells grow and spread, rather than preventing the initial mutations that cause cancer.
Vitamin K2: Promising Lab Results, Limited Human Data
Vitamin K2 has shown real anti-cancer activity in laboratory and animal studies, particularly against pancreatic, liver, and lung cancer cells. It works by disrupting energy production inside cancer cells and triggering a self-destruct process called apoptosis. In liver cancer animal models, K2 at therapeutic doses significantly reduced tumor growth. When combined with existing cancer drugs, it enhanced their ability to kill cancer cells even at doses that were ineffective on their own.
These findings are genuinely interesting, but they haven’t translated into large human trials yet. The gap between shrinking tumors in a dish and preventing cancer in a living person is enormous, so K2 shouldn’t be treated as an established cancer-fighting supplement.
Intravenous Vitamin C: Not the Same as Supplements
High-dose vitamin C delivered intravenously (not orally) is being studied as an add-on to standard cancer treatment, particularly for pancreatic cancer. A systematic review of clinical trials found that adding IV vitamin C to chemotherapy or radiation may improve survival and help patients tolerate treatment better, with minimal additional side effects. The mechanism is counterintuitive: at very high blood concentrations only achievable through an IV, vitamin C generates a reactive compound that selectively damages cancer cells while leaving healthy cells relatively unharmed.
This is a clinical treatment administered in medical settings, not something you can replicate by taking vitamin C tablets. Oral vitamin C tops out at much lower blood levels because your gut limits absorption. And there’s an important caveat: some evidence suggests that oral vitamin C taken during chemotherapy could actually interfere with treatment by protecting cancer cells from the damage that drugs like cisplatin and doxorubicin are designed to inflict. In one study, this protective shielding affected more than 10% of participants.
Vitamins That Can Increase Cancer Risk
This is where the research takes a sharp turn that surprises most people. Several vitamins, taken as high-dose supplements, have been convincingly linked to higher cancer rates.
Vitamin E and Prostate Cancer
The SELECT trial, one of the largest cancer prevention studies ever conducted, tracked over 35,000 men and found that those taking 400 IU of vitamin E daily had a 17% higher risk of developing prostate cancer compared to those on placebo. This wasn’t a small or ambiguous finding. The trial was stopped early because the supplements were clearly not helping and appeared to be causing harm.
Beta-Carotene and Lung Cancer in Smokers
Two landmark trials, ATBC and CARET, tested whether beta-carotene supplements could prevent lung cancer in smokers. Both found the opposite. The ATBC study reported 18% more lung cancer cases in the supplement group, while CARET found 28% more cases and 17% higher overall mortality. The increased risk applied regardless of cigarette type. Men smoking the lightest cigarettes had a 31% higher lung cancer risk with beta-carotene, and those smoking the heaviest had a 22% increase. If you smoke or recently quit, beta-carotene supplements are actively dangerous.
High-Dose B6 and B12
Long-term supplementation with high doses of B6 (over 20 milligrams daily) and B12 (over 55 micrograms daily) for 10 years or more has been associated with a two- to four-fold increase in lung cancer risk among men. Male smokers were hit hardest: those taking high-dose B6 were three times more likely to develop lung cancer, and those on high-dose B12 were roughly four times more likely compared to non-users. These are the doses commonly found in “energy” and “metabolism” supplement blends, not the amounts in a standard multivitamin.
Folate: Timing Changes Everything
Folate is essential for DNA repair, which sounds like it should help prevent cancer. And in healthy tissue, it likely does by reducing the rate of harmful mutations. But folate also fuels cell division, and rapidly growing tissues, including tumors, have a greater need for it. Animal studies consistently show that folate supplementation before precancerous changes develop reduces cancer risk, while supplementation after precancerous lesions already exist accelerates tumor growth.
A clinical trial in people with a history of colorectal polyps confirmed this pattern in humans. Participants taking 1 milligram of folic acid daily had a 67% higher risk of developing advanced polyps and more than double the risk of developing multiple polyps over 6 to 8 years. When folate supplementation begins late in life, its net effect on cancer risk appears small and mostly harmful. This is why antifolate drugs have been used in cancer chemotherapy since the 1940s: starving tumors of folate slows their growth.
Antioxidant Supplements During Cancer Treatment
If you’re undergoing radiation or chemotherapy, antioxidant supplements deserve special caution. Many cancer treatments work by generating massive oxidative stress inside tumor cells. Antioxidants, by definition, neutralize that stress. In a randomized trial of head and neck cancer patients receiving radiation, those taking 400 IU of vitamin E daily had more than double the rate of new cancers developing afterward compared to the placebo group (60 per 1,000 person-years versus 25). The risk was even higher among smokers, because smoking already reduces the oxygen levels that radiation depends on to kill tumors.
This creates a genuine dilemma. Vitamin E did reduce some of the painful side effects of radiation. But if it also allows the cancer to survive treatment, the tradeoff is clearly unfavorable.
Daily Multivitamins: No Cancer Benefit Found
The COSMOS trial, a large randomized study of over 21,000 older adults followed for a median of 3.6 years, found that a daily multivitamin did not reduce cancer incidence. The cancer rate was nearly identical in the multivitamin and placebo groups. This doesn’t mean multivitamins are harmful for most people, but it does mean they aren’t a cancer prevention tool.
The American Cancer Society recommends getting nutrients from whole foods rather than supplements. Diets rich in fruits, vegetables, and fiber consistently show cancer-protective associations in population studies, and the benefit likely comes from the complex mix of compounds in whole foods rather than any isolated vitamin. Supplements deliver single nutrients at unnaturally high doses, which, as the evidence above shows, can backfire in ways that whole foods do not.